Related Experiment Video
Updated: Nov 17, 2025

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
MicroRNAs and Diabetes Mellitus Type 1
Farbod Bahreini1,2, Elham Rayzan3,4, Nima Rezaei2,3,5
1Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
Abstract:
Type 1 diabetes mellitus is a multifactorial, progressive, autoimmune disease with a strong genetic feature that can affect multiple organs, including the kidney, eyes, and nerves. Early detection of type 1 diabetes can help critically to avoid serious damages to these organs. MicroRNAs are small RNA molecules that act in post-transcriptional gene regulation by attaching to the complementary sequence in the 3'-untranslated region of their target genes. Alterations in the expression of microRNA coding genes are extensively reported in several diseases, such as type 1 diabetes. Presenting non-invasive biomarkers for early detection of type 1 diabetes by quantifying microRNAs gene expression level can be a significant step in biotechnology and medicine. This review discusses the area of microRNAs dysregulation in type 1 diabetes and affected molecular mechanisms involved in pancreatic islet cell formation and dysregulation in the expression of inflammatory elements as well as pro-inflammatory cytokines.
Insights
Early detection of type 1 diabetes is crucial. MicroRNA gene expression offers a promising, non-invasive biomarker for identifying this autoimmune disease and preventing organ damage.
Area of Science:
- Biochemistry
- Genetics
- Immunology
Background:
- Type 1 diabetes mellitus is a progressive autoimmune disease with genetic factors, potentially damaging organs like kidneys, eyes, and nerves.
- Early detection of type 1 diabetes is critical for preventing severe organ damage.
- MicroRNAs are key regulators of gene expression, and their altered expression is linked to various diseases, including type 1 diabetes.
Purpose of the Study:
- To review the dysregulation of microRNAs in type 1 diabetes.
- To explore the molecular mechanisms underlying microRNA involvement in pancreatic islet cell development and inflammation.
Main Methods:
- Literature review focusing on microRNA dysregulation in type 1 diabetes.
- Analysis of molecular mechanisms in pancreatic islet cell formation.
- Examination of inflammatory element and cytokine expression.
Main Results:
- Alterations in microRNA expression are reported in type 1 diabetes.
- MicroRNAs play a role in pancreatic islet cell development and inflammatory processes.
- Quantifying microRNA gene expression may serve as a non-invasive biomarker.
Conclusions:
- MicroRNA dysregulation is implicated in the pathogenesis of type 1 diabetes.
- MicroRNAs are involved in key molecular pathways affected in type 1 diabetes, including islet cell formation and inflammation.
- MicroRNA quantification presents a potential non-invasive diagnostic approach for early type 1 diabetes detection.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
MicroRNAs
MicroRNAs
Diabetes: Symptoms, Diagnosis, and Complications

